1. Signaling Pathways
  2. Anti-infection
  3. Antibiotic
  4. Quinolone Isoform

Quinolone

 

Quinolone Related Products (82):

Cat. No. Product Name Effect Purity
  • HY-B0356
    Ciprofloxacin
    99.86%
    Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor.
  • HY-B0330
    Levofloxacin
    99.84%
    Levofloxacin ((-)-Ofloxacin) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria.
  • HY-B1046
    Clofazimine
    99.23%
    Clofazimine is an iminophenazine dye, has a marked anti-inflammatory effect, has been used in combination with other antimycobacterial drugs to treat AIDS and Crohn's disease.
  • HY-B0356A
    Ciprofloxacin monohydrochloride
    99.78%
    Ciprofloxacin (Bay-09867) monohydrochloride is a potent, orally active topoisomerase IV inhibitor.
  • HY-14814A
    Delafloxacin meglumine
    99.03%
    Delafloxacin meglumine (ABT492 meglumine; RX-3341 meglumine; WQ-3034 meglumine) is a broad-spectrum fluoroquinolone antibiotic.
  • HY-A0147A
    Grepafloxacin hydrochloride
    99.23%
    Grepafloxacin (OPC-17116) hydrochloride is an oral actively fluoroquinolone antibiotic with potent activity against community-acquired respiratory pathogens including Streptococcus pneumonia.
  • HY-B0395A
    Sitafloxacin hydrochloride
    Sitafloxacin (DU6859a) hydrochloride is a potent, orally active fluoroquinolone antibiotic.
  • HY-111023
    Nemonoxacin malate
    Nemonoxacin (TG-873870) malate is a nonfluorinated quinolone antibiotic.
  • HY-66011
    Moxifloxacin Hydrochloride
    99.51%
    Moxifloxacin Hydrochloride (BAY 12-8039) is an oral 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
  • HY-17647
    Zoliflodacin
    99.95%
    Zoliflodacin (ETX0914;AZD0914) is a novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor.
  • HY-66011A
    Moxifloxacin
    99.48%
    Moxifloxacin is an orally active 8-methoxyquinolone antimicrobial for use in the treatment of acute bacterial sinusitis, acute bacterial exacerbations of chronic bronchitis, and community-acquired pneumonia.
  • HY-B0125
    Ofloxacin
    99.76%
    Ofloxacin (Hoe-280) is a fluoroquinolone whose primary mechanism of action is inhibition of bacterial DNA gyrase.
  • HY-B0502
    Enrofloxacin
    99.95%
    Enrofloxacin (BAY Vp 2674) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.
  • HY-B0398
    Nalidixic acid
    99.99%
    Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria.
  • HY-A0170
    Trovafloxacin
    98.22%
    Trovafloxacin is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive, Gram-negative and anaerobic organisms.
  • HY-B0502A
    Enrofloxacin monohydrochloride
    99.53%
    Enrofloxacin monohydrochloride (BAY Vp 2674 monohydrochloride) is an effective antibiotic with an MIC90 of 0.312 μg/mL for Mycoplasma bovis.
  • HY-B0132
    Norfloxacin
    98.29%
    Norfloxacin (MK-0366) is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria, which functions by inhibiting DNA gyrase.
  • HY-B0308
    Sparfloxacin
    99.92%
    Sparfloxacin (CI-978) is a fluoroquinolone antibiotic, shows broad and potent antibacterial activity.
  • HY-B0343A
    Sarafloxacin hydrochloride
    98.38%
    Sarafloxacin (hydrochloride) (A-56620 (hydrochloride)) is a quinolone antibiotic drug.
  • HY-B1085
    Cinoxacin
    99.99%
    Cinoxacin (Compound 64716), a synthetic antimicrobial related to the quinolone class of orally active antibacterial agent.